Neuromyelitis optica spectrum disorders: still evolving and broadening

por Fujihara, Kazuo
Publicado 2019

Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?

por Fujihara, Kazuo, Nakashima, Ichiro
Publicado 2014

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide

por Hor, Jyh Yung, Fujihara, Kazuo
Publicado 2023

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum d...

por Takai, Yoshiki, Misu, Tatsuro, Fujihara, Kazuo, Aoki, Masashi
Publicado 2023

Patterns of cortical grey matter thickness reduction in multiple sclerosis

por Fujimori, Juichi, Fujihara, Kazuo, Wattjes, Mike, Nakashima, Ichiro
Publicado 2021

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications

por Passos, Giordani Rodrigues Dos, Sato, Douglas Kazutoshi, Becker, Jefferson, Fujihara, Kazuo
Publicado 2016

Epitope Analysis of Cerebrospinal Fluid IgG in Japanese Multiple Sclerosis Patients Using Phage Display Method

por Fujimori, Juichi, Nakashima, Ichiro, Fujihara, Kazuo, Misu, Tatsuro, Sato, Shigeru, Itoyama, Yasuto
Publicado 2011

Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation

por Tateyama, Maki, Fujihara, Kazuo, Misu, Tatsuro, Arai, Akira, Kaneta, Tomohiro, Aoki, Masashi
Publicado 2015

Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief...

por Fujimori, Juichi, Nakashima, Ichiro, Baba, Toru, Meguro, Yuko, Ogawa, Ryo, Fujihara, Kazuo
Publicado 2017

Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing...

por Nakashima, Ichiro, Nakahara, Jin, Yokote, Hiroaki, Manabe, Yasuhiro, Okamura, Kazumi, Hasegawa, Kou, Fujihara, Kazuo
Publicado 2023

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder

por Namatame, Chihiro, Misu, Tatsuro, Takai, Yoshiki, Nishiyama, Shuhei, Nakashima, Ichiro, Fujihara, Kazuo, Aoki, Masashi
Publicado 2021

Differential diagnosis of neuromyelitis optica spectrum disorders

por Kim, Sung-Min, Kim, Seong-Joon, Lee, Haeng Jin, Kuroda, Hiroshi, Palace, Jacqueline, Fujihara, Kazuo
Publicado 2017

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin

por Matsumoto, Yuki, Tsuchiya, Mario, Norshalena, Shakespear, Kaneko, Chikako, Kubo, Jin, Yamamoto, Teiji, Takahashi, Toshiyuki, Fujihara, Kazuo
Publicado 2018

Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica

por Kariya, Yoshinobu, Kariya, Yukiko, Saito, Toshie, Nishiyama, Shuhei, Honda, Takashi, Tanaka, Keiko, Yoshida, Mari, Fujihara, Kazuo, Hashimoto, Yasuhiro
Publicado 2015

Serological markers associated with neuromyelitis optica spectrum disorders in South India

por Pandit, Lekha, Sato, Douglas Kazutoshi, Mustafa, Sharik, Takahashi, Toshiyuki, D’Cunha, Anitha, Malli, Chaithra, Sudhir, Akshatha, Fujihara, Kazuo
Publicado 2016

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India

por Pandit, Lekha, Sato, Douglas Kazutoshi, Mustafa, Sharik, Takahashi, Toshiyuki, D’Cunha, Anitha, Malli, Chaithra, Sudhir, Akshatha, Fujihara, Kazuo
Publicado 2016

Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis

por Akaishi, Tetsuya, Takahashi, Toshiyuki, Fujihara, Kazuo, Misu, Tatsuro, Mugikura, Shunji, Abe, Michiaki, Ishii, Tadashi, Aoki, Masashi, Nakashima, Ichiro
Publicado 2020

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders

por Akaishi, Tetsuya, Takahashi, Toshiyuki, Misu, Tatsuro, Abe, Michiaki, Ishii, Tadashi, Fujimori, Juichi, Aoki, Masashi, Fujihara, Kazuo, Nakashima, Ichiro
Publicado 2020

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats

por Kitic, Maja, Hochmeister, Sonja, Wimmer, Isabella, Bauer, Jan, Misu, Tatsuro, Mader, Simone, Reindl, Markus, Fujihara, Kazuo, Lassmann, Hans, Bradl, Monika
Publicado 2013

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO

por Higuchi, Osamu, Nakane, Shunya, Sakai, Waka, Maeda, Yasuhiro, Niino, Masaaki, Takahashi, Toshiyuki, Fukazawa, Toshiyuki, Kikuchi, Seiji, Fujihara, Kazuo, Matsuo, Hidenori
Publicado 2016